Metformin abuse and weight loss: A case report

Table 2 Patient’s laboratory findings

	Day 6 (August 29, 2022)	Day 7 (August 30, 2022)	Day 8 (August 31, 2022)	Day 11 (September 3, 2022)	Day 19 (September 11, 2022)
Amylase (Reference: 0-104 U/L)	410		342		228
Creatinine (Reference: 0.6-1.2 mg/dL)	5.32	5.53	5.77	2.99	0.75
Urea (Reference: 7-20 mg/dL)	96	90	91	63	17
Alanine transaminase (Reference: 0-40 U/L)	753	1186	775	204	35
Aspartate aminotransferase (Reference: 0-40 U/L)			297		17
Bilirubin (Total, direct) (Reference: Total 2.0-1.2 mg/dL, direct 0-0.3 mg/dL)		Total: 1.16; Direct: 0.94
Albumin (Reference: 3.2-5.0 g/dL)	135.0				3.6
Globulin (Reference: 2.7-3.3 g/dL)	3.6
Total proteins (Reference: 6.4-8.3 g/dL)	4.6
Prothrombin time (Reference: 11-15 Seconds)	34.9	19.7	17.7
Partial thromboplastin time (Reference: 25-40 Seconds)	39	37	32
International normalized ratio (Reference: 0.8-1.2)	3.40	1.73	1.52
Bicarbonate (Reference 22-28 mEq/L)
Partial pressure of oxygen (Reference: 75-100 mmHg)
C-reactive protein (Reference: < 0.5 mg/dL)		4.52	4.49		1.13
Procalcitonin (Reference: Up to 0.5 ng/dL)		71.2	33.6
Sodium (Reference: 135-145 mmol/L)		135.0	133.0	133.0	146.6
Potassium (Reference: 3.5-5.0 mmol/L)		3.90	3.70	2.64	4.57